Investment ThemesDetailed Quotes
Gene Editing Watchlist

Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.

  • 1514.083
  • -38.396-2.47%
Close Aug 2 16:00 ET
1548.211High1501.977Low
Constituent Stocks: 10Top Rising: SGMO+23.72%
Intraday
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y
Constituent Stocks
SymbolStock Name
Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
WatchlistPaper Trade
SGMOSangamo Therapeutics
0.8710.166+23.61%20.17M15.35M0.6500.7050.8790.629180.78M148.94M207.51M170.95M+0.73%+119.39%+170.14%+61.36%+51.67%-26.17%+60.35%--11.80%LossLoss35.46%Biotechnology
BLUEbluebird bio
1.1100.030+2.78%3.78M4.03M1.0401.0801.1101.020213.94M213.00M192.74M191.89M-9.02%+5.71%+20.22%+9.90%+7.77%-71.39%-19.57%--1.97%LossLoss8.33%Biotechnology
APLSApellis Pharmaceuticals
36.5550.555+1.54%2.45M88.49M35.80036.00037.12034.8404.45B3.00B121.77M82.10M-8.04%-3.75%+0.87%-16.73%-46.68%+49.02%-38.93%--2.99%LossLoss6.33%Biotechnology
VRTXVertex Pharmaceuticals
494.460-11.320-2.24%1.55M771.18M491.500505.780508.650491.000127.62B127.23B258.10M257.32M-0.16%+0.59%+4.19%+20.53%+16.92%+45.22%+21.52%--0.60%Loss35.603.49%Biotechnology
AAgilent Technologies
139.040-3.820-2.67%2.30M319.03M141.980142.860143.170135.76040.57B40.41B291.76M290.65M+1.25%+5.51%+10.03%-1.40%+4.64%+10.88%+0.36%0.66%0.79%32.9533.185.19%Diagnostics & Research
EDITEditas Medicine
5.000-0.140-2.72%1.85M9.22M4.9905.1405.0854.885411.19M381.94M82.24M76.39M-11.50%0.00%+8.93%-11.97%-32.89%-44.75%-50.64%--2.43%LossLoss3.89%Biotechnology
CRBUCaribou Biosciences
2.130-0.110-4.91%927.08K1.97M2.1102.2402.1852.071192.38M147.28M90.32M69.15M-14.46%-7.19%+33.13%-42.90%-69.26%-68.30%-62.83%--1.34%LossLoss5.09%Biotechnology
NTLAIntellia Therapeutics
23.850-1.290-5.13%1.32M31.16M23.99025.14024.25023.0002.30B2.27B96.48M95.24M-10.00%-4.90%+4.79%-0.13%-15.52%-39.79%-21.78%--1.38%LossLoss4.97%Biotechnology
CRSPCRISPR Therapeutics
51.110-3.740-6.82%2.56M130.19M53.00054.85053.15049.7304.34B4.26B84.92M83.37M-11.76%-6.32%-3.75%-7.96%-27.00%+0.29%-18.35%--3.07%LossLoss6.24%Biotechnology
BEAMBeam Therapeutics
27.430-2.880-9.50%1.37M37.48M28.65030.31028.79026.5452.26B2.10B82.31M76.56M-17.23%+5.74%+18.85%+21.75%-5.58%+1.14%+0.77%--1.79%LossLoss7.41%Biotechnology

Comments

Read more